| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4566601
Max Phase: Preclinical
Molecular Formula: C11H12N2O2
Molecular Weight: 204.23
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: C#CCN(C)Cc1ccc([N+](=O)[O-])cc1
Standard InChI: InChI=1S/C11H12N2O2/c1-3-8-12(2)9-10-4-6-11(7-5-10)13(14)15/h1,4-7H,8-9H2,2H3
Standard InChI Key: NWNXUWFSKKBDGX-UHFFFAOYSA-N
Associated Targets(Human)
Pyrroline-5-carboxylate reductase 1, mitochondrial 71 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 204.23 | Molecular Weight (Monoisotopic): 204.0899 | AlogP: 1.66 | #Rotatable Bonds: 4 |
| Polar Surface Area: 46.38 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 7.27 | CX LogP: 2.08 | CX LogD: 1.84 |
| Aromatic Rings: 1 | Heavy Atoms: 15 | QED Weighted: 0.43 | Np Likeness Score: -1.79 |
References
| 1. Milne K, Sun J, Zaal EA, Mowat J, Celie PHN, Fish A, Berkers CR, Forlani G, Loayza-Puch F, Jamieson C, Agami R.. (2019) A fragment-like approach to PYCR1 inhibition., 29 (18): [PMID:31362921] [10.1016/j.bmcl.2019.07.047] |
Source
Source(1):